Access to therapy is part of the protection of the constitutional order: Peter Bely spoke at the SPIEF session on intellectual property
19.12.2022
Production
Industry development
19.12.2022
Saransk. December 19th. INTERFAX — JSC Biochemist (Saransk, part of the Promomed group of companies) has commissioned a new workshop with a capacity of 1 billion tablets per year, the press service of the head of Mordovia reported.
Investments in the organization of production exceeded 1.8 billion rubles.
The lines of the new workshop are designed to produce antiviral, nonsteroidal anti-inflammatory, and hepatoprotective drugs. It is reported that the production of drugs in the form of sachets will be launched here in the near future.
"Promomed Group's new production facility is one of the most modern in Europe. (. . .) It is equipped with the most modern technologies, including for the manufacture of multilayer and composite tablets produced in conditions of photosensitivity and zero humidity," the report says.
The launch ceremony was attended by Deputy Minister of Health of Russia Sergey Glagolev, Chairman of the Federation Council Committee on Defense and Security Viktor Bondarev, First Deputy Chairman of the State Duma Health Committee Fedot Tumusov, Head of Mordovia Artem Zdunov and Chairman of the Board of Directors of Promomed Group Peter Bely.
The head of Mordovia noted that Promomed's new production facility contributes to Russia's technological independence.
"We can produce the necessary equipment, train people, and go all the way to protect intellectual property. We are dealing with the safety and lives of people, and we act as a single team. We are already thinking about the next stage of production, new investments and markets," Zdunov said in a statement.
As previously reported, with reference to the head of Mordovia, Promomed Group intends to invest up to 20 billion rubles in the development of Saransk Biochemist over 4 years.
Biochemist is a Promomed Group production site. Promomed Pharmaceutical holding's portfolio includes about 200 names of medicines, 80% of which are included in the list of VED and included in the list of methodological recommendations for the Prevention, diagnosis and treatment of new coronavirus infection (COVID-19) by the Russian Ministry of Health.
A source: interfax-russia.ru
Sources
Get the most interesting news and publications first!
Sent successfully!
Press office
To request a press release or interview, please contact our press office
